Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Medullary thyroid cancer with RET V804M mutation: more indolent than expected?

Surgery - 1 Jan 2023

Frisco Nicholas A, Gunn Alexander H, Thomas Samantha M, Stang Michael T, Scheri Randall P, Kazaure Hadiza S

Abstract excerpt

BACKGROUND: Significant genotype-phenotype variability among multiple endocrine neoplasia type 2A patients with a RET V804M mutation has been reported. METHODS: Patients with a RET V804M mutation treated at a single center were identified (January 1996-December 2020). The baseline characteristics, operative details, pathology, biochemical, and long-term data were analyzed. RESULTS: There were 79 patients; none...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenal Gland Neoplasms
Share to Calcitonin
Share to Carcinoma, Medullary

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiple Endocrine Neoplasia Type 2a

Share to Proto-Oncogene Mas

Share to Proto-Oncogene Proteins c-ret

Share to Thyroid Neoplasms

Share to Thyroidectomy

Source

Identifiers

PMID: 36150924
DOI: 10.1016/j.surg.2022.05.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Medullary thyroid cancer with RET V804M mutation: more indolent than expected?PMID 36150924Read ↗

Fundamentals and recent advances in the evaluation and management of medullary thyroid carcinoma.Semantic proximity Read ↗

Precision management of medullary thyroid carcinoma: a dynamic framework integrating biomarkers, genotyping, and risk stratification.Semantic proximity Read ↗

Untitled literature recordSemantic proximity Read ↗

Genetics of medullary thyroid cancer: An overview.Semantic proximity Read ↗

Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence.Semantic proximity Read ↗

Approach to the Patient: Hereditary Medullary Thyroid CarcinomaSemantic proximity Read ↗

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.Semantic proximity Read ↗

Update on Multiple Endocrine Neoplasia Type 2: Focus on Medullary Thyroid CarcinomaSemantic proximity Read ↗

Systemic treatment and management approaches for medullary thyroid cancer.Semantic proximity Read ↗

Prevalence by Age and Predictors of Medullary Thyroid Cancer in Patients with Lower Risk Germline <i>RET</i> Proto-Oncogene MutationsSemantic proximity Read ↗

A primer on the genetics of medullary thyroid cancer.Semantic proximity Read ↗

Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.